Abstract:Introduction Crigler-Najjar 1 (CN1) due to exon 3 mutations of the UGT1A1 gene is a not rare genetic disease in Tunisia with a founder effect. CN1 syndrome is very severe, and most of CN1 Tunisian patients die soon after birth, within a maximum of one year, due to kernicterus. Liver transplantation, which is the only available therapeutic method for CN1, remains unreachable. Objectives The aim of this study was to report behavioral and neurocognitive phenotypes in CN1 patients who survived to school enrollment. Methods We have selected all patients evaluated from 2004 to 2010, both clinically and molecularly, for a deficiency of bilirubin-UGT enzyme activity leading to a pathological elevation of unconjugated bilirubin with a suspicion of CN1 syndrome. Direct sequencing of targeted PCR amplification products was performed for molecular analysis of UGT1A1. Behavioral and mental features of patients were studied through our genetic counselling. Results We identified 15 patients with the homozygous c.1070 A>G Tunisian mutation. Their age at diagnosis ranged from one week to 9 months for 13 patients. Six of them died within a month of molecular investigation. Only two boys were of school age, i.e. 6 and 9 years. The first had been hospitalized at 3 months year-old for a prolonged jaundice treated with phenobarbital and phototherapy. His psychomotor and neurological development was normal, with school attendance at the age of six. The second patient presented with an unexplored jaundice at the age of 3 days, which was later complicated by seizures and treated with phenobarbital. Despite neurological and motor sequelae associated to language impairments with slurred speech, he attended school at the age of six. Conclusions The neurological and behavioral profile of CN1 patients depends on familial and medical management. Quick diagnosis, close follow up and early liver transplantation can improve prognosis. Disclosure of Interest None Declared

Congenital sucrase–isomaltase deficiency in Türkiye; a single center experience

Congenital Sucrase-Isomaltase Deficiency: Same Mutation with Different Clinical Presentations

Genetic and acquired sucrase‐isomaltase deficiency: A clinical review

The patient journey to diagnosis and treatment of congenital sucrase-isomaltase deficiency

The sucrose challenge symptoms test optimized for diagnosis of congenital sucrase isomaltase deficiency

Single-center experience of congenital disorders of glycosylation syndrome screening in Tunisia: A retrospective study over a 15-year period (2007-2021)

Clinical and Molecular Characterization of Mucopolysaccharidosis Type 3A and 3B in a Turkish Series

[Genetic and clinical analysis of a child with Shwachman-Diamond syndrome due to compound heterozygous variants of SBDS gene]

Fucosidosis: clinical and molecular findings of Turkish patients

VARIATIONS IN MONOGENIC DIABETES AND DIABETES SUSCEPTIBILITY GENES IN PEDIATRIC CASES: SINGLE CENTER EXPERIENCE

Behavioral and neurocognitive phenotypes in Crigler-Najjar syndrome in Tunisia

Congenital Short-Bowel Syndrome: Clinical and Genetic Presentation in China

A Turkish patient with novel AHCY variants and presumed diagnosis of S‐adenosylhomocysteine hydrolase deficiency

Severe combined immunodeficiencies: Expanding the mutation spectrum in Turkey and identification of 12 novel variants

The evaluation of inherited metabolic diseases presenting with rhabdomyolysis from Turkey: Single center experience

β-Globin Gene Mutations in Pediatric Patients with β-Thalassemia in the Region of Çukurova, Turkey

CTNS Mutations Causing Autosomal Recessive Cystinosis in a Subset of Iranian Population: Report of Two New Variants

Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b

Novel Mutation in the HSD17B10 Gene Accompanied by Dysmorphic Findings in Female Patients

Analyzing the Distribution of Mutations for Glycogen Storage Disease Type 1a in Turkey and Suggested Gene Therapy Methods for Its Treatment

Epidemiological and clinical characteristics of 66 Tunisian Sickle cell syndrome patients